FDA Drug Application (202491) for OLMESARTAN MEDOXOMIL; AMLODIPINE; HYDROCHLOROTHIAZIDE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number202491
Product Number001
FormTABLET;ORAL
Dosage20MG;5MG;12.5MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOLMESARTAN MEDOXOMIL; AMLODIPINE; HYDROCHLOROTHIAZIDE
Active IngredientOLMESARTAN MEDOXOMIL;AMLODIPINE;HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE2
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient OLMESARTAN MEDOXOMIL11


Back to FDA Applications sponsored by TEVA PHARMS USA